Finance
Teva Q1 2026 slides: innovative drugs surge 41%, Emalex deal expands CNS
Teva Q1 2026 slides: innovative drugs surge 41%, Emalex deal expands CNS
I
Investing.com
April 29, 2026·1 min read
Image: Investing.com
Teva Q1 2026 slides: innovative drugs surge 41%, Emalex deal expands CNS
Original article
Teva Q1 2026 slides: innovative drugs surge 41%, Emalex deal expands CNS
Published by Investing.com